AmSurg Reports First-Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Jefferies Has Bullish View on AmSurg (AMSG) Post Q1; PT Raised to $76
May 6, 2015 9:35 AM EDTJefferies maintains a Buy rating for AmSurg (NASDAQ: AMSG) and raises the price target to $76 (from $68). It is believed that the earnings and growth that came along with the recent acquisition of Sheridan, along with ongoing improvements, will drive multiple expansions over the next 12... More
Amsurg (AMSG) Tops Q1 EPS by 5c, Raises FY Guidance
May 5, 2015 4:33 PM EDTAmsurg (NASDAQ: AMSG) reported Q1 EPS of $0.62, $0.05 better than the analyst estimate of $0.57. Revenue for the quarter came in at $570.4 million versus the consensus estimate of $574.3 million.
Amsurg sees FY2015 EPS of $3.31-$3.39, versus prior guidance of $3.24-$3.32 and the consensus of $3.26. Amsurg... More
